4543
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Terumo Corporation is a medical technology company organized into four business segments: Cardiovascular, Medical Care Solutions, Blood & Cell Technologies, and Organ Technologies. The group develops and manufactures medical devices and solutions for cardiovascular care, blood management, and organ support. In October 2025, the company acquired all shares of Organox, Ltd., making it a wholly-owned subsidiary and establishing the Organ Technologies segment. The corporate group consists of the parent company, 101 consolidated subsidiaries, and four equity-method affiliates.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Medical Devices Homepage terumo.com
Sector Healthcare IR page —
Tags
cardiovascular devices, blood management, cell technologies, organ support, medical care solutions, Organox Ltd.
Press page —

Metrics

Valuation  
Market cap ¥ 3.372T
Market cap (USD) $ 21.128B
P/E 29.57
PEG 1.97
P/BV 2.11
P/S 2.76
P/OCF 12.11
P/FCF 18.90
Dividend yield 1.3%
Turnover / mcap —
Returns  
ROE 9.2%
ROI 6.9%
ROIC 6.8%
Profit margin 12.0%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 15.0%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 31.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 1.132T 1.036T 921.863B 820.209B 703.303B 613.842B 628.897B 599.481B 587.775B 514.164B 525.026B 489.506B 467.359B 402.294B
Net profit 135.914B 116.978B 106.374B 89.325B 88.813B 77.268B 85.211B 79.47B 75.59B 54.225B 50.676B 38.47B 34.096B 47.014B
Free cash flow 128.889B 128.437B 67.556B 45.363B 87.952B 38.361B 55.163B 54.245B — 44.344B 47.391B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 2.108K 2.797K 2.729K 3.574K 3.724K 3.999K 3.72K 3.38K 5.589K 3.865K 4.035K 3.17K 2.253K 2.025K
Price performance 12m -0.25 0.02 -0.24 -0.04 -0.07 0.08 0.1 -0.4 0.45 -0.04 0.27 0.41 0.11 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 110B 121B 128B 132B 129B 136B 151B 179B 177B 215B
↳ YoY growth +4.9% +5.8% +2.5% -2.2% +5.6% +10.8% +18.6% -1.0% +21.5%
↳ 5y CAGR +4.4% +6.8% +6.1% +10.8%
Borrowings, current (JPY) 128B 47.4B — 50.3B 42.1B 1.12B 11.2B 157B 15B 280B
Borrowings, non-current (JPY) 211B 289B 225B 196B 218B 225B 221B 75B 160B 99.9B
Bonds payable (JPY) 130B — — — — — — — — —
Lease liabilities (JPY) 461M — — — — — — — — —
Cash and deposits (JPY) 105B 168B 123B 167B 201B 205B 187B 205B 222B 280B
Intangible assets (JPY) 455B — — — — — — — — —
Net debt (borrowings + leases - cash) (JPY) 234B 168B 102B 79.3B 59.8B 20.7B 44.6B 27B -47B 99.3B
Cash flow detail
Operating cash flow (JPY) 80.9B 112B 93.6B 117B 121B 141B 118B 146B 211B 231B
Purchases of property, plant and equipment (JPY) -29.8B -31.9B -39.3B -62.3B -62.3B -53.5B -52.7B -60.7B -68.6B -85.2B
Purchases of intangible assets (JPY) -6.68B -9.46B -15B -21.2B -20.8B -20.6B -19.5B -18B -13.7B -16.8B
Change in receivables (cash effect) (JPY) -4.78B -9.26B -5.94B -7.32B 6.42B -895M -8.48B -16.4B -4.61B -23.4B
Change in inventories (cash effect) (JPY) -3.92B -7.54B -20.1B -17.3B -22B -8.17B -39.3B -9.21B -11.6B -7.02B
Change in payables (cash effect) (JPY) 886M 3.99B 6.68B 3.44B -814M 55M 10.5B -5B 1.84B -6.74B
Dividends paid (cash effect) (JPY) -14.5B -15.8B -19.6B -20.5B -21.2B -23.5B -27.9B -32B -35.6B -41.3B
Share buybacks (cash effect) (JPY) -44.2B -6M -9M -3M -3M -3M -50.1B -11.1B -30.1B -1M
Interest paid (cash effect) (JPY) -1.19B -1.13B -1.12B -956M -1.06B -1.31B -1.37B -1.3B -1.71B -2.76B
Income taxes paid (cash effect) (JPY) -24.8B — — — — — — — — —
Operating cash flow before change in receivables (JPY) 85.6B 124B 99.5B 125B 115B 142B 126B 163B 215B 254B
Free cash flow (OCF - PPE - intangibles) (JPY) 44.3B 73.2B 39.2B 34B 38.4B 67.4B 45.4B 67.6B 128B 129B
Income detail
Research and development expense (JPY) 33.7B 41.3B 47.7B 50.6B 49.1B 51.8B 61.6B 69.1B 74.2B 76.9B
↳ 5y CAGR +8.3% +7.7% +8.0% +9.4%
Total comprehensive income (JPY) 36.5B 55.1B 98.9B 59.2B 116B 178B 176B 259B 107B 257B
Comprehensive income to owners (JPY) 49.7B 67.7B 99.1B 59.4B 116B 178B 176B 259B 107B 257B
Segments
Blood And Cell Technologies Company · Segment revenue (JPY) — — 105B 107B 109B 121B 148B 168B 200B 231B
↳ YoY growth +2.1% +2.2% +10.1% +22.4% +14.0% +19.0% +15.4%
Blood And Cell Technologies Company · Segment operating income (JPY) — — 15.7B 15.1B 19.1B 20.8B 11.2B 16.4B 26.5B 33.6B
Blood Management Company · Segment revenue (JPY) — 105B 105B — — — — — — —
↳ YoY growth +0.3%
Blood Management Company · Segment operating income (JPY) — 15.1B 15.7B — — — — — — —
Cardiac And Vascular Company · Segment revenue (JPY) — 324B 329B 351B 329B 397B 481B 556B 624B 676B
↳ YoY growth +1.4% +6.7% -6.3% +20.9% +21.0% +15.6% +12.4% +8.3%
Cardiac And Vascular Company · Segment operating income (JPY) — 83.6B 80.9B 86.9B 74.4B 93.2B 112B 124B 155B 164B
General Hospital Company · Segment revenue (JPY) — 159B 166B 171B 176B — — — — —
↳ YoY growth +4.4% +3.1% +2.7%
General Hospital Company · Segment operating income (JPY) — 26.8B 26.8B 25.2B 25.7B — — — — —
Medical Care Solutions Company · Segment revenue (JPY) — — — — 176B 185B 192B 198B 211B 216B
↳ YoY growth +5.6% +3.5% +3.0% +6.9% +2.3%
Medical Care Solutions Company · Segment operating income (JPY) — — — — 25.7B 23.6B 14.8B 19.8B 23B 21.6B
Terumo Organ Technologies · Segment revenue (JPY) — — — — — — — — — 7.99B
Terumo Organ Technologies · Segment operating income (JPY) — — — — — — — — — 1.67B
Reported Jun 25, 2018 Jun 24, 2019 Jun 26, 2020 Jun 26, 2020 Jun 23, 2022 Jun 23, 2022 Jun 28, 2023 Jun 27, 2024 Jun 23, 2025 Jun 23, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Terumo Corporation (ticker 4543), listed in Japan.

ETFs Holding Terumo Corporation

ETF Weight in ETF Shares Market value As of
AIVI 0.23% 9,700 $ 133.332K Jun 30, 2026
UMMA 0.22% 40,676 $ 640.852K Aug 31, 2026
NTSI 0.11% 38,700 $ 531.954K Jun 30, 2026
DFAI 0.09% 1,024,400 $ 16.388M Nov 12, 2026
DFIC 0.07% 715,000 $ 11.438M Nov 12, 2026
DXIV 0.05% 8,000 $ 127.98K Nov 12, 2026
DFSI 0.05% 35,900 $ 574.31K Nov 12, 2026
AVDE 0.04% 493,900 $ 7.545M Nov 16, 2026
DFAX 0.02% 182,600 $ 2.921M Nov 12, 2026
AVSD 0.00% 1,000 $ 15.276K Nov 16, 2026